Abstract
Purpose
Aim of this study was to investigate the prevalence of methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum (ESBL) and plasmid-mediated AmpC beta-lactamase producing Gram-negative bacteria in children.
Methods
Antibiotic susceptibility of MRSA and beta-lactamase producing Gram-negative bacteria was determined by disc diffusion and broth microdilution methods according to CLSI guidelines. Methicillin resistance was confirmed by the presence of mecA gene by PCR. The genetic characterization of S. aures was performed using spa-typing and the algorithm based upon repeat pattern (BURP). Double-disk synergy test was used to screen for ESBL production. PCR was used to detect bla ESBL alleles. Genetic relatedness of the strains was tested by pulsed-field gel electrophoresis (PFGE).
Results
Among 23 MRSA, 12 (52.2 %) were obtained from newborns. MLST CC152 (spa-CC 355–595) (Balkan clone) was the most prevalent, 20 (87 %) cases. Among 24 beta-lactamase producing Gram-negative bacteria, 10 (41.7 %) were obtained from each newborns and one-year-old children; 14 (58.3 %) were from urine. Among 11 Klebsiella strains isolated from urine eight (73 %) produced CTX-M-15, and one CTX-M-3 beta-lactamase. Twenty (83 %) of CTX-M producers were coproduced by other types of beta-lactamases. Fifteen (65.2 %) MRSA isolates were clonally related. Five clones among 13 K. pneumoniae isolates were detected by PFGE suggesting clonal spread of β-lactamase producing Gram-negative bacteria.
Conclusion
Pediatric infections caused by clonal spread of MRSA and beta-lactamase-producing Gram-negative bacteria are of major concern. Proper infection control measures should be implemented in order to avoid the transmission and major outbreaks.
Zusammenfassung
Ziel
Ziel dieser Studie war es, die Prävalenz der Infektionen durch Methicillin-resistenten Staphylococcus aureus (MRSA) und gram-negative Bakterien bei Kindern zu untersuchen, die Beta-Laktamasen mit erweiterten Wirkungsspektrum (ESBL) und AmpC Beta-Laktamasen produzieren.
Methoden
Empfindlichkeit der MRSA- und ESBL-Isolaten gegenüber Antibiotika wurde durch die Disk-Diffusions- und Mikrodilutionsmethode gem. den CLSI-Standards bestimmt. Methicillin-Resistenz wurde durch die Anwesenheit des mecA Gens durch PCR bestätigt. Die genetische Charakterisierung von S. aures erfolgte mittels spa-Typisierung und den algorithm based upon repeat pattern (BURP). Die ESBL-Produktion wurde anhand vom Doppelt-synergetischen Test, und die bla ESBL –Allele wurden durch PCR bestimmt. Genetische Verwandtschaft der Stämme wurde durch Puls-Feld-Gelelektrophorese (PFGE) getestet.
Ergebnisse
Unter 23 MRSA wurden 12 (52,2 %) von Neugeborenen erhalten. MLST CC152 (spa-CC 355–595) (Balkan-Klon) war mit 20 Fällen (87 %) der häufigste. Unter 24 Beta-Laktamasen produzierenden gram-negativen Bakterien wurden jeweils 10 (41,7 %) bei den Neugeborenen und den Einjährigen isoliert. 14 (58,3 %) stammten aus dem Urin. Unter 11 Klebsiella-Stämmen aus dem Urin waren 8 (73 %) CTX-M-15 und einer CTX-M-3 Beta-Laktamase. Zwanzig CTX-M Hersteller (83 %) produzierten auch andere Arten von Beta-Laktamasen. Fünfzehn MRSA-Isolate (65,2 %) gehörten demselben Klon. Unter 13 K. pneumoniae Isolate wurden fünf Klone erkannt, wodurch klonale Ausbreitung der die Beta-Laktamasen produzierenden gram-negativen Bakterien suggeriert wird.
Schlussfolgerung
Die Ergebnisse dieser Studie zeigten, wie wichtig die Einführung von Screening auf MRSA und ESBL-produzierende gram-negative Bakterien bei der Krankenhausaufnahme ist. Es ist notwendig, geeignete Maßnahmen zur Infektionskontrolle zu implementieren, um die Ausbreitung von Infektionen und Seuchen zu verhindern
Similar content being viewed by others
References
Mollema FPN, Richards JH, Behrendt M, Vaessen N, Lodder W, Hendriks W, Verbrugh HA, Vos MC. Transmission of methicillin-resistant Staphylococcus aureus to household contacts. J Clin Microbiol. 2010;48(1):202–7.
Regev-Yochay G, Rubinstein E, Barzilai A, Carmeli Y, Kuint J, Etienne J, Blech M, Smollen G, Maayan-Metzger A, Leavitt A, Rahav G, Keller N. Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit. Emerg Infect Dis. 2005;11(3):453–56.
Donker GA, Deurenberg RH, Driessen C, Sebastian S, Nys S, Stobberingh EE. The population structure of Staphylococcus aureus among general practice patients from The Netherlands. Clin Microbiol Infect. 2009;15(2):137–43.
Jacoby GA. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect Dis Clin North Am. 1997;11(4):875–87.
Lartigue M-F, Zinsius C, Wenger A, Bille J, Poirel, L, Nordmann P. Extended-Spectrum β-Lactamases of the CTX-M Type Now in Switzerland. Antimicrob Agents Chemother. 2007;51(8):2855–60.
Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657–86.
Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore DM. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2004;54(4):735–43.
Literacka E, Bedenić B, Baraniak A, Fiett J, Tonkić M, Jajić-Bencić I, Gniadkowski M. BlaCTX-M genes in Escherichia coli from Croatian hospitals are located in new (blaCTX-M-3) and widely spread (blaCTX-M-3a, blaCTX-M-15) genetic structures. Antimicrob Agents Chemother. 2009;53(4):1630–5.
Eisner A, Fagan EJ, Feierl G, Kessler HH, Marth E, Livermore DM, Woodford N. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria. Antimicrob Agents Chemother. 2006;50(2):785–7.
Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Perilli M, Amicosante G, Stefani S, Toniolo A, Rossolini G-M. CTX-M-type extended-spectrum β-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother. 2006;50(2):2700–6.
Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153–62.
Andriatahina T, Randrianirina F, Hariniana ER, Talarmin A, Raobijaona H, Buisson Y, Richard V. High prevalence of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar. BMC Infect Dis. 2010;10:204.
Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS. Prevalence of newer β-lactamases in gram-negative clinical isolates collected in the United States from 2001–2002. J Clin Microbiol. 2006;44(9):3318–24.
Uzunović-Kamberović S, Rijnders MIA, Stobberingh EE, Ibrahimagić A, Kamberović F, Ille T. Molecular characterization of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in inpatients and outpatients in Bosnia and Herzegovina. Wien Med Wochenschr. 2013;163(1–2):13–20.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Tenth Informational Supplement M100-S18. Wayne PA, USA:CLSI;2009.
Melles DC, Gorkink RFJ, Boelens HAM, Snijders SV, Peeters JK, Moorhouse MJ, van der Spek PJ, van Leeuwen WB, Simons G, Verbrugh HA. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Investig. 2004;114(12):1732–40.
Strommenger B, Braulke C, Heuck D, Harmsen D, Friedrich AW, Witte W. Assignment of Staphylococcus isolates to group by spa typing, SmaI macrorestriction analyisis, and multilocus sequence typing. J Clin Microbiol. 2006; 4(7):2533–40.
Ruppitsch W, Indra A, Stoger A, Mayer B, Stadlbauer S, Wewalka G, Allerberger F. Clasifying spa types in complexes improves interpretation of typing results for methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2006;44(7):2442–8.
Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10(4):867–78.
Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian V. Antibiotics in laboratory medicine. 2nd ed. Baltimore: Williams and Wilkins;1986. p. 683–721.
Arlet G, Brami G, Decre D, Flippo A, Gaillot O, Lagrange PH, Philippon A. Molecular characterization by PCR restriction fragment polymorphism of TEM β-lactamases. FEMS Microbiol Lett. 1995;134(2–3):203–8.
Kaufman ME. Pulsed-field gel electrophoresis. In: Woodfor N, Johnsons A, editors. Molecular biology. Protocols and clinical applications. 1st ed. New York: Humana Press Inc. 1998. P. 33–51.
Tenover FC, Arbeit RD, Goerling RV, Mickelsen PA, Murray BE, Persing DH, Swiminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis; criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233–9.
O’Brien FG, Coombs GW, Pearman JW, Gracey M, Moss F, Christiansen KJ, Grubb WB. Population dynamics of methicillin-susceptible and -resistant Staphylococcus aureus in remote communities. J Antimicrob Chemother. 2009;64(4):684–93.
Ugolotti E, Bandettini R, Marchese A, Gualco L, Vanni I, Borzi L, Di Marco E, Castagnola E, Melioli G, Biassoni R. Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. Diagn Microbiol Infect Dis. 2011;69(2):213–7.
Cirkovic I, Sorum M, Radenkovic D, Svabic Vlahovic M, Larsen AR. National surveillance reveals the first findings of Panton Valentine leukocidin positive methicillin-resistant Staphylococcus aureus in Serbia. J Med Microbiol. 2013;62:(Pt 2) 342–4.
Al Naiemi N, Bart A, de Jong MD, Vandenbroucke-Grauls CM, Rietra PJ, Debets-Ossenkopp JY, Wever PC, Spanjaard L, Bos AJ, Duim B. Widely distributed and predominant CTX-M extended-spectrum β-lactamases in Amsterdam, The Netherlands. J Clin Microbiol. 2006;44(8):3012–4.
Uzunovic-Kamberovic S, Bedenic B, Vranes J. Predominance of SHV-β- lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina. Clin Microbiol Infect. 2007;3(8):820–3.
Wang A, Yang Y, Lu Q, Wang Y, Chen Y, Deng L, Ding H, Deng Q, Wang L, Shen X. Occurrence of qnr-positive clinical isolates in Klebsiella pneumoniae producing ESBL or AmpC-type β-lactamase from five pediatric hospitals in China. FEMS Microbiol Lett. 2008;283(1):112–6.
Acknowledgments
This work was supported by a grant from the Federation Ministry of Education and Science, Bosnia and Herzegovina.
Conflict of interest
Selma Uzunović, Branka Bedenić, Ana Budimir, Farah Kamberović, Amir Ibrahimagić, Sabina Delić-Bikić, Sara Sivec, Tomislav Meštrović, Dijana Varda Brkić, Michelle I. A. Rijnders, and Ellen E. Stobberingh declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uzunović, S., Bedenić, B., Budimir, A. et al. Emergency (clonal spread) of methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum (ESBL) – and AmpC beta-lactamase-producing Gram-negative bacteria infections at Pediatric Department, Bosnia and Herzegovina. Wien Klin Wochenschr 126, 747–756 (2014). https://doi.org/10.1007/s00508-014-0597-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-014-0597-2